Evidence map›Paper›PMID 25080073›Full record

ArticleNeuropharmacology2014

Interoceptive conditioning with nicotine using extinction and re-extinction to assess stimulus similarity with bupropion.

Sergios Charntikov, Nicole R deWit, Rick A Bevins

Abstract read
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sergios CharntikovDepartment of Psychology, 238 Burnett Hall, University of Nebraska-Lincoln, Lincoln, NE 68588-0308, USA.
Nicole R deWitDepartment of Psychology, 238 Burnett Hall, University of Nebraska-Lincoln, Lincoln, NE 68588-0308, USA.
Rick A BevinsDepartment of Psychology, 238 Burnett Hall, University of Nebraska-Lincoln, Lincoln, NE 68588-0308, USA. Electronic address: rbevins1@unl.edu.
University of Nebraska–Lincoln · US

Funding

Pharmacological interventions to diminish nicotine associated respondingR01DA034389 · NIDA · UNIVERSITY OF NEBRASKA LINCOLN · PI BEVINS, RICK A · 2012 to 2016
$1.4M
Acquired Appetitive Properties of NicotineR01DA018114 · NIDA · UNIVERSITY OF NEBRASKA LINCOLN · PI BEVINS, RICK A · 2004 to 2010
$1.4M
Role of dmCPu in acquisition and expression of nicotine CS evoked CRF31DA034449 · NIDA · UNIVERSITY OF NEBRASKA LINCOLN · PI CHARNTIKOV, SERGIOS · 2013 to 2014
$74k
NIDA NIH HHS DA018114NIDA NIH HHS DA034389NIDA NIH HHS F31 DA034449NIDA NIH HHS R01 DA018114NIDA NIH HHS R01 DA034389
6 · The paper itself

Abstract

Bupropion is an atypical antidepressant that increases long-term quit rates of tobacco smokers. A better understanding of the relation between nicotine and this first-line medication may provide insight into improving treatment. For all experiments, rats first had nicotine (0.4 mg base/kg) and saline session intermixed; intermittent access to sucrose only occurred on nicotine session. Nicotine in this protocol comes to differentially control "anticipatory" dipper entries. To more closely examine the overlap in the interoceptive stimulus effects of nicotine and bupropion, we assessed whether subsequent prolonged and repeated non-reinforced (extinction) sessions with the bupropion stimulus could weaken responding to nicotine (i.e., transfer of extinction). We also examined whether retraining the discrimination after initial extinction and then conducting extinction again (i.e., re-extinction) with bupropion would affect responding. We found that bupropion (20 and 30 mg/kg) fully substituted for the nicotine stimulus in repeated 20-min extinction sessions. The extent of substitution in extinction did not necessarily predict performance in the transfer test (e.g., nicotine responding unchanged after extinction with 20 mg/kg bupropion). Generalization of extinction back to nicotine was not seen with 20 mg/kg bupropion even after increasing the number of extinction session from 6 to 24. Finally, there was evidence that learning in the initial extinction phase was retained in the re-extinction phase for nicotine and bupropion. These findings indicate that learning involving the nicotine stimuli are complex and that assessment approach for stimulus similarity changes conclusions regarding substitution by bupropion. Further research will be needed to identify whether such differences may be related to different facets of nicotine dependence and/or its treatment.

Indexed as

AnimalsBupropionConditioning, PsychologicalDiscrimination, PsychologicalDopamine Uptake InhibitorsDose-Response Relationship, RadiationExtinction, PsychologicalMaleNicotineNicotinic AgonistsRats, Sprague-DawleyTransfer, PsychologyBupropionDopamine Uptake InhibitorsNicotineNicotinic AgonistsBupropionDiscriminated goal-tracking taskExtinctionInteroceptive conditioningNicotineRe-extinction

Identifiers

PMID25080073
PMCPMC4188736
OpenAlexW2063732703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.